首站-论文投稿智能助手
典型文献
Role of IL?17 family cytokines in the progression of IPF from inflammation to fibrosis
文献摘要:
Idiopathic pulmonary fibrosis (IPF) is a fatal chronic interstitial lung disease with no established treatment and is characterized by progressive scarring of the lung tissue and an irreversible decline in lung function. Chronic inflammation has been demonstrated to be the pathological basis of fibrosis. Emerging studies have revealed that most interleukin-17 (IL-17) isoforms are essential for the mediation of acute and chronic inflammation via innate and adaptive immunity. Overexpression or aberrant expression of IL-17 cytokines contributes to various pathological outcomes, including the initiation and exacerbation of IPF. Here, we aim to provide an overview of IL-17 family members in the pathogenesis of IPF.
文献关键词:
作者姓名:
Yun?Juan Nie;Shuo?Hua Wu;Ying?Hua Xuan;Gen Yan
作者机构:
Department of Basic Medicine,Wuxi School of Medicine,Jiangnan University,Wuxi 214000,Jiangsu,China;Department of Radiology,the Second Affiliated Hospital,Medical College of Shantou University,Shantou 515000,Guangdong,China;Department of Basic Medicine,Xiamen Medical College,Xiamen 361000,Fujian,China;Department of Radiology,the Second Affiliated Hospital of Xiamen Medical College,Xiamen 361000,Fujian,China
引用格式:
[1]Yun?Juan Nie;Shuo?Hua Wu;Ying?Hua Xuan;Gen Yan-.Role of IL?17 family cytokines in the progression of IPF from inflammation to fibrosis)[J].军事医学研究(英文),2022(05):618-627
A类:
B类:
Role,family,cytokines,progression,IPF,from,inflammation,fibrosis,Idiopathic,pulmonary,fatal,chronic,interstitial,lung,disease,no,established,treatment,characterized,by,progressive,scarring,tissue,irreversible,decline,function,Chronic,has,been,demonstrated,pathological,basis,Emerging,studies,have,revealed,that,most,interleukin,isoforms,are,essential,mediation,acute,via,innate,adaptive,immunity,Overexpression,aberrant,contributes,various,outcomes,including,initiation,exacerbation,Here,we,aim,provide,overview,members,pathogenesis
AB值:
0.660075
相似文献
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
Jian Sun;Tongzhu Jin;Zhihui Niu;Jiayu Guo;Yingying Guo;Ruoxuan Yang;Qianqian Wang;Huiying Gao;Yuhan Zhang;Tianyu Li;Wenxin He;Zhixin Li;Wenchao Ma;Wei Su;Liangliang Li;Xingxing Fan;Hongli Shan;Haihai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Northern Translational Medicine Research and Cooperation Center,Heilongjiang Academy of Medical Sciences,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Thoracic Surgery,Shanghai Pulmonary Hospital,Tongji University,Shanghai 200433,China;State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health,Macau University of Science and Technology,Macau(SAR),China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice
Qiu-yan Zhang;Su-jing Xu;Jian-chang Qian;Li-bin Yang;Peng-qin Chen;Yi Wang;Xiang Hu;Ya-li Zhang;Wu Luo;Guang Liang-Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China;Medical Research Center,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School and Hospital of Stomatology,Wenzhou Medical University,Wenzhou 325027,China;Department of Endocrinology,The First Affiliated Hospital,Wenzhou Medical University,Wenzhou 325035,China;School of Pharmaceutical Sciences,Hangzhou Medical College,Hangzhou 311399,China;Wenzhou Institute,University of Chinese Academy of Sciences,Wenzhou 325001,China
Pirfenidone ameliorates silica-induced lung inflammation and fibrosis in mice by inhibiting the secretion of interleukin-17A
Zhu-jie Cao;Ying Liu;Zhe Zhang;Pei-ran Yang;Zhao-guo Li;Mei-yue Song;Xian-mei Qi;Zhi-fa Han;Jun-ling Pang;Bai-cun Li;Xin-ri Zhang;Hua-ping Dai;Jing Wang;Chen Wang-State Key Laboratory of Medical Molecular Biology,Institute of Basic Medical Sciences,Chinese Academy of Medical Sciences,Beijing 100005,China;Department of Pathophysiology,Peking Union Medical College,Beijing 100005,China;Department of Pulmonary and Critical Care Medicine,the First Hospital of Shanxi Medical University,Taiyuan 030001,China;Department of Respiratory,the Second Affiliated Hospital of Harbin Medical University,Harbin 150086,China;Beijing University of Chinese Medicine,Beijing 100029,China;Department of Pulmonary and Critical Care Medicine,Center of Respiratory Medicine,China-Japan Friendship Hospital,Beijing 100029,China;National Center for Respiratory Medicine;Institute of Respiratory Medicine,Chinese Academy of Medical Sciences;National Clinical Research Center for Respiratory Diseases,Beijing 100029,China
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
CDDO-Im ameliorates osteoarthritis and inhibits chondrocyte apoptosis in mice via enhancing Nrf2-dependent autophagy
Jian Dong;Kai-jia Zhang;Gao-cai Li;Xing-ren Chen;Jia-jia Lin;Jia-wei Li;Zhong-yang Lv;Zhao-zhi Deng;Jin Dai;Wangsen Cao;Qing Jiang-Division of Sports Medicine and Adult Reconstructive Surgery,Department of Orthopedic Surgery,State Key Laboratory of Pharmaceutical Biotechnology,Nanjing Drum Tower Hospital,The Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China;Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Department of Critical Care Medicine,Jinling Hospital,School of Medicine,Nanjing University Medical School,Nanjing 210003,China;Center for Organ Fibrosis and Remodeling Research,Jiangsu Key Lab of Molecular Medicine,Nanjing University Medical School,Nanjing 210093,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。